Global Antibody Discovery and Development Services Market Outlook, In‑Depth Analysis & Forecast to 2031

1 Study Coverage
1.1 Introduction to Antibody Discovery and Development Services: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Antibody Discovery and Development Services Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Antibody Discovery Services
1.2.3 Antibody Production Services
1.3 Market Segmentation by Application
1.3.1 Global Antibody Discovery and Development Services Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical
1.3.3 Research
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Antibody Discovery and Development Services Revenue Estimates and Forecasts 2020-2031
2.2 Global Antibody Discovery and Development Services Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Antibody Discovery and Development Services Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Antibody Discovery and Development Services Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Antibody Discovery Services Market Size by Players
3.3.2 Antibody Production Services Market Size by Players
3.4 Global Antibody Discovery and Development Services Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Antibody Discovery and Development Services Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Antibody Discovery and Development Services Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Antibody Discovery and Development Services Market Size by Type (2020-2031)
6.4 North America Antibody Discovery and Development Services Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Antibody Discovery and Development Services Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Antibody Discovery and Development Services Market Size by Type (2020-2031)
7.4 Europe Antibody Discovery and Development Services Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Antibody Discovery and Development Services Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Antibody Discovery and Development Services Market Size by Type (2020-2031)
8.4 Asia-Pacific Antibody Discovery and Development Services Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Antibody Discovery and Development Services Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Antibody Discovery and Development Services Market Size by Type (2020-2031)
9.4 Central and South America Antibody Discovery and Development Services Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Antibody Discovery and Development Services Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Antibody Discovery and Development Services Market Size by Type (2020-2031)
10.4 Middle East and Africa Antibody Discovery and Development Services Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Antibody Discovery and Development Services Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Abcam
11.1.1 Abcam Corporation Information
11.1.2 Abcam Business Overview
11.1.3 Abcam Antibody Discovery and Development Services Product Features and Attributes
11.1.4 Abcam Antibody Discovery and Development Services Revenue and Gross Margin (2020-2025)
11.1.5 Abcam Antibody Discovery and Development Services Revenue by Product in 2024
11.1.6 Abcam Antibody Discovery and Development Services Revenue by Application in 2024
11.1.7 Abcam Antibody Discovery and Development Services Revenue by Geographic Area in 2024
11.1.8 Abcam Antibody Discovery and Development Services SWOT Analysis
11.1.9 Abcam Recent Developments
11.2 Abzena
11.2.1 Abzena Corporation Information
11.2.2 Abzena Business Overview
11.2.3 Abzena Antibody Discovery and Development Services Product Features and Attributes
11.2.4 Abzena Antibody Discovery and Development Services Revenue and Gross Margin (2020-2025)
11.2.5 Abzena Antibody Discovery and Development Services Revenue by Product in 2024
11.2.6 Abzena Antibody Discovery and Development Services Revenue by Application in 2024
11.2.7 Abzena Antibody Discovery and Development Services Revenue by Geographic Area in 2024
11.2.8 Abzena Antibody Discovery and Development Services SWOT Analysis
11.2.9 Abzena Recent Developments
11.3 AlivaMab Biologics
11.3.1 AlivaMab Biologics Corporation Information
11.3.2 AlivaMab Biologics Business Overview
11.3.3 AlivaMab Biologics Antibody Discovery and Development Services Product Features and Attributes
11.3.4 AlivaMab Biologics Antibody Discovery and Development Services Revenue and Gross Margin (2020-2025)
11.3.5 AlivaMab Biologics Antibody Discovery and Development Services Revenue by Product in 2024
11.3.6 AlivaMab Biologics Antibody Discovery and Development Services Revenue by Application in 2024
11.3.7 AlivaMab Biologics Antibody Discovery and Development Services Revenue by Geographic Area in 2024
11.3.8 AlivaMab Biologics Antibody Discovery and Development Services SWOT Analysis
11.3.9 AlivaMab Biologics Recent Developments
11.4 Alloy Therapeutics
11.4.1 Alloy Therapeutics Corporation Information
11.4.2 Alloy Therapeutics Business Overview
11.4.3 Alloy Therapeutics Antibody Discovery and Development Services Product Features and Attributes
11.4.4 Alloy Therapeutics Antibody Discovery and Development Services Revenue and Gross Margin (2020-2025)
11.4.5 Alloy Therapeutics Antibody Discovery and Development Services Revenue by Product in 2024
11.4.6 Alloy Therapeutics Antibody Discovery and Development Services Revenue by Application in 2024
11.4.7 Alloy Therapeutics Antibody Discovery and Development Services Revenue by Geographic Area in 2024
11.4.8 Alloy Therapeutics Antibody Discovery and Development Services SWOT Analysis
11.4.9 Alloy Therapeutics Recent Developments
11.5 Antibody Solutions
11.5.1 Antibody Solutions Corporation Information
11.5.2 Antibody Solutions Business Overview
11.5.3 Antibody Solutions Antibody Discovery and Development Services Product Features and Attributes
11.5.4 Antibody Solutions Antibody Discovery and Development Services Revenue and Gross Margin (2020-2025)
11.5.5 Antibody Solutions Antibody Discovery and Development Services Revenue by Product in 2024
11.5.6 Antibody Solutions Antibody Discovery and Development Services Revenue by Application in 2024
11.5.7 Antibody Solutions Antibody Discovery and Development Services Revenue by Geographic Area in 2024
11.5.8 Antibody Solutions Antibody Discovery and Development Services SWOT Analysis
11.5.9 Antibody Solutions Recent Developments
11.6 Aragen Bioscience
11.6.1 Aragen Bioscience Corporation Information
11.6.2 Aragen Bioscience Business Overview
11.6.3 Aragen Bioscience Antibody Discovery and Development Services Product Features and Attributes
11.6.4 Aragen Bioscience Antibody Discovery and Development Services Revenue and Gross Margin (2020-2025)
11.6.5 Aragen Bioscience Recent Developments
11.7 Aurigene Pharmaceutical Services
11.7.1 Aurigene Pharmaceutical Services Corporation Information
11.7.2 Aurigene Pharmaceutical Services Business Overview
11.7.3 Aurigene Pharmaceutical Services Antibody Discovery and Development Services Product Features and Attributes
11.7.4 Aurigene Pharmaceutical Services Antibody Discovery and Development Services Revenue and Gross Margin (2020-2025)
11.7.5 Aurigene Pharmaceutical Services Recent Developments
11.8 Biocytogen
11.8.1 Biocytogen Corporation Information
11.8.2 Biocytogen Business Overview
11.8.3 Biocytogen Antibody Discovery and Development Services Product Features and Attributes
11.8.4 Biocytogen Antibody Discovery and Development Services Revenue and Gross Margin (2020-2025)
11.8.5 Biocytogen Recent Developments
11.9 Biomolecular Discovery Services
11.9.1 Biomolecular Discovery Services Corporation Information
11.9.2 Biomolecular Discovery Services Business Overview
11.9.3 Biomolecular Discovery Services Antibody Discovery and Development Services Product Features and Attributes
11.9.4 Biomolecular Discovery Services Antibody Discovery and Development Services Revenue and Gross Margin (2020-2025)
11.9.5 Biomolecular Discovery Services Recent Developments
11.10 Biotem
11.10.1 Biotem Corporation Information
11.10.2 Biotem Business Overview
11.10.3 Biotem Antibody Discovery and Development Services Product Features and Attributes
11.10.4 Biotem Antibody Discovery and Development Services Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Charles River Laboratories
11.11.1 Charles River Laboratories Corporation Information
11.11.2 Charles River Laboratories Business Overview
11.11.3 Charles River Laboratories Antibody Discovery and Development Services Product Features and Attributes
11.11.4 Charles River Laboratories Antibody Discovery and Development Services Revenue and Gross Margin (2020-2025)
11.11.5 Charles River Laboratories Recent Developments
11.12 ChemPartner
11.12.1 ChemPartner Corporation Information
11.12.2 ChemPartner Business Overview
11.12.3 ChemPartner Antibody Discovery and Development Services Product Features and Attributes
11.12.4 ChemPartner Antibody Discovery and Development Services Revenue and Gross Margin (2020-2025)
11.12.5 ChemPartner Recent Developments
11.13 Creative Bioarray
11.13.1 Creative Bioarray Corporation Information
11.13.2 Creative Bioarray Business Overview
11.13.3 Creative Bioarray Antibody Discovery and Development Services Product Features and Attributes
11.13.4 Creative Bioarray Antibody Discovery and Development Services Revenue and Gross Margin (2020-2025)
11.13.5 Creative Bioarray Recent Developments
11.14 Creative Biolabs
11.14.1 Creative Biolabs Corporation Information
11.14.2 Creative Biolabs Business Overview
11.14.3 Creative Biolabs Antibody Discovery and Development Services Product Features and Attributes
11.14.4 Creative Biolabs Antibody Discovery and Development Services Revenue and Gross Margin (2020-2025)
11.14.5 Creative Biolabs Recent Developments
11.15 Curia
11.15.1 Curia Corporation Information
11.15.2 Curia Business Overview
11.15.3 Curia Antibody Discovery and Development Services Product Features and Attributes
11.15.4 Curia Antibody Discovery and Development Services Revenue and Gross Margin (2020-2025)
11.15.5 Curia Recent Developments
11.16 Eurofins
11.16.1 Eurofins Corporation Information
11.16.2 Eurofins Business Overview
11.16.3 Eurofins Antibody Discovery and Development Services Product Features and Attributes
11.16.4 Eurofins Antibody Discovery and Development Services Revenue and Gross Margin (2020-2025)
11.16.5 Eurofins Recent Developments
11.17 Evotec
11.17.1 Evotec Corporation Information
11.17.2 Evotec Business Overview
11.17.3 Evotec Antibody Discovery and Development Services Product Features and Attributes
11.17.4 Evotec Antibody Discovery and Development Services Revenue and Gross Margin (2020-2025)
11.17.5 Evotec Recent Developments
11.18 GenScript
11.18.1 GenScript Corporation Information
11.18.2 GenScript Business Overview
11.18.3 GenScript Antibody Discovery and Development Services Product Features and Attributes
11.18.4 GenScript Antibody Discovery and Development Services Revenue and Gross Margin (2020-2025)
11.18.5 GenScript Recent Developments
11.19 Integrated DNA Technologies
11.19.1 Integrated DNA Technologies Corporation Information
11.19.2 Integrated DNA Technologies Business Overview
11.19.3 Integrated DNA Technologies Antibody Discovery and Development Services Product Features and Attributes
11.19.4 Integrated DNA Technologies Antibody Discovery and Development Services Revenue and Gross Margin (2020-2025)
11.19.5 Integrated DNA Technologies Recent Developments
11.20 LakePharma
11.20.1 LakePharma Corporation Information
11.20.2 LakePharma Business Overview
11.20.3 LakePharma Antibody Discovery and Development Services Product Features and Attributes
11.20.4 LakePharma Antibody Discovery and Development Services Revenue and Gross Margin (2020-2025)
11.20.5 LakePharma Recent Developments
11.21 MorphoSys
11.21.1 MorphoSys Corporation Information
11.21.2 MorphoSys Business Overview
11.21.3 MorphoSys Antibody Discovery and Development Services Product Features and Attributes
11.21.4 MorphoSys Antibody Discovery and Development Services Revenue and Gross Margin (2020-2025)
11.21.5 MorphoSys Recent Developments
11.22 NanoCellect
11.22.1 NanoCellect Corporation Information
11.22.2 NanoCellect Business Overview
11.22.3 NanoCellect Antibody Discovery and Development Services Product Features and Attributes
11.22.4 NanoCellect Antibody Discovery and Development Services Revenue and Gross Margin (2020-2025)
11.22.5 NanoCellect Recent Developments
11.23 ProteoGenix
11.23.1 ProteoGenix Corporation Information
11.23.2 ProteoGenix Business Overview
11.23.3 ProteoGenix Antibody Discovery and Development Services Product Features and Attributes
11.23.4 ProteoGenix Antibody Discovery and Development Services Revenue and Gross Margin (2020-2025)
11.23.5 ProteoGenix Recent Developments
11.24 Rapid Novor
11.24.1 Rapid Novor Corporation Information
11.24.2 Rapid Novor Business Overview
11.24.3 Rapid Novor Antibody Discovery and Development Services Product Features and Attributes
11.24.4 Rapid Novor Antibody Discovery and Development Services Revenue and Gross Margin (2020-2025)
11.24.5 Rapid Novor Recent Developments
11.25 Sanofi
11.25.1 Sanofi Corporation Information
11.25.2 Sanofi Business Overview
11.25.3 Sanofi Antibody Discovery and Development Services Product Features and Attributes
11.25.4 Sanofi Antibody Discovery and Development Services Revenue and Gross Margin (2020-2025)
11.25.5 Sanofi Recent Developments
11.26 Syd Labs
11.26.1 Syd Labs Corporation Information
11.26.2 Syd Labs Business Overview
11.26.3 Syd Labs Antibody Discovery and Development Services Product Features and Attributes
11.26.4 Syd Labs Antibody Discovery and Development Services Revenue and Gross Margin (2020-2025)
11.26.5 Syd Labs Recent Developments
11.27 Twist Bioscience
11.27.1 Twist Bioscience Corporation Information
11.27.2 Twist Bioscience Business Overview
11.27.3 Twist Bioscience Antibody Discovery and Development Services Product Features and Attributes
11.27.4 Twist Bioscience Antibody Discovery and Development Services Revenue and Gross Margin (2020-2025)
11.27.5 Twist Bioscience Recent Developments
11.28 Yumab
11.28.1 Yumab Corporation Information
11.28.2 Yumab Business Overview
11.28.3 Yumab Antibody Discovery and Development Services Product Features and Attributes
11.28.4 Yumab Antibody Discovery and Development Services Revenue and Gross Margin (2020-2025)
11.28.5 Yumab Recent Developments
11.29 Viva Biotech
11.29.1 Viva Biotech Corporation Information
11.29.2 Viva Biotech Business Overview
11.29.3 Viva Biotech Antibody Discovery and Development Services Product Features and Attributes
11.29.4 Viva Biotech Antibody Discovery and Development Services Revenue and Gross Margin (2020-2025)
11.29.5 Viva Biotech Recent Developments
11.30 WuXi Biologics
11.30.1 WuXi Biologics Corporation Information
11.30.2 WuXi Biologics Business Overview
11.30.3 WuXi Biologics Antibody Discovery and Development Services Product Features and Attributes
11.30.4 WuXi Biologics Antibody Discovery and Development Services Revenue and Gross Margin (2020-2025)
11.30.5 WuXi Biologics Recent Developments
12 Antibody Discovery and Development ServicesIndustry Chain Analysis
12.1 Antibody Discovery and Development Services Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Antibody Discovery and Development Services Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Antibody Discovery and Development Services Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

List of Tables
Table 1. Global Antibody Discovery and Development Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Antibody Discovery and Development Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Antibody Discovery and Development Services Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Antibody Discovery and Development Services Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Antibody Discovery and Development Services Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Antibody Discovery and Development Services Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Antibody Discovery and Development Services Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Antibody Discovery and Development Services by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Discovery and Development Services as of 2024)
Table 11. Global Antibody Discovery and Development Services Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Antibody Discovery and Development Services Companies Headquarters
Table 13. Global Antibody Discovery and Development Services Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Antibody Discovery and Development Services Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Antibody Discovery and Development Services Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Antibody Discovery and Development Services Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Antibody Discovery and Development Services Revenue by Application (2026-2031) & (US$ Million)
Table 21. Antibody Discovery and Development Services High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Antibody Discovery and Development Services Growth Accelerators and Market Barriers
Table 25. North America Antibody Discovery and Development Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Antibody Discovery and Development Services Growth Accelerators and Market Barriers
Table 27. Europe Antibody Discovery and Development Services Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Antibody Discovery and Development Services Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Antibody Discovery and Development Services Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Antibody Discovery and Development Services Investment Opportunities and Key Challenges
Table 31. Central and South America Antibody Discovery and Development Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Antibody Discovery and Development Services Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Antibody Discovery and Development Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Abcam Corporation Information
Table 35. Abcam Description and Major Businesses
Table 36. Abcam Product Features and Attributes
Table 37. Abcam Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Abcam Revenue Proportion by Product in 2024
Table 39. Abcam Revenue Proportion by Application in 2024
Table 40. Abcam Revenue Proportion by Geographic Area in 2024
Table 41. Abcam Antibody Discovery and Development Services SWOT Analysis
Table 42. Abcam Recent Developments
Table 43. Abzena Corporation Information
Table 44. Abzena Description and Major Businesses
Table 45. Abzena Product Features and Attributes
Table 46. Abzena Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Abzena Revenue Proportion by Product in 2024
Table 48. Abzena Revenue Proportion by Application in 2024
Table 49. Abzena Revenue Proportion by Geographic Area in 2024
Table 50. Abzena Antibody Discovery and Development Services SWOT Analysis
Table 51. Abzena Recent Developments
Table 52. AlivaMab Biologics Corporation Information
Table 53. AlivaMab Biologics Description and Major Businesses
Table 54. AlivaMab Biologics Product Features and Attributes
Table 55. AlivaMab Biologics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. AlivaMab Biologics Revenue Proportion by Product in 2024
Table 57. AlivaMab Biologics Revenue Proportion by Application in 2024
Table 58. AlivaMab Biologics Revenue Proportion by Geographic Area in 2024
Table 59. AlivaMab Biologics Antibody Discovery and Development Services SWOT Analysis
Table 60. AlivaMab Biologics Recent Developments
Table 61. Alloy Therapeutics Corporation Information
Table 62. Alloy Therapeutics Description and Major Businesses
Table 63. Alloy Therapeutics Product Features and Attributes
Table 64. Alloy Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Alloy Therapeutics Revenue Proportion by Product in 2024
Table 66. Alloy Therapeutics Revenue Proportion by Application in 2024
Table 67. Alloy Therapeutics Revenue Proportion by Geographic Area in 2024
Table 68. Alloy Therapeutics Antibody Discovery and Development Services SWOT Analysis
Table 69. Alloy Therapeutics Recent Developments
Table 70. Antibody Solutions Corporation Information
Table 71. Antibody Solutions Description and Major Businesses
Table 72. Antibody Solutions Product Features and Attributes
Table 73. Antibody Solutions Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Antibody Solutions Revenue Proportion by Product in 2024
Table 75. Antibody Solutions Revenue Proportion by Application in 2024
Table 76. Antibody Solutions Revenue Proportion by Geographic Area in 2024
Table 77. Antibody Solutions Antibody Discovery and Development Services SWOT Analysis
Table 78. Antibody Solutions Recent Developments
Table 79. Aragen Bioscience Corporation Information
Table 80. Aragen Bioscience Description and Major Businesses
Table 81. Aragen Bioscience Product Features and Attributes
Table 82. Aragen Bioscience Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Aragen Bioscience Recent Developments
Table 84. Aurigene Pharmaceutical Services Corporation Information
Table 85. Aurigene Pharmaceutical Services Description and Major Businesses
Table 86. Aurigene Pharmaceutical Services Product Features and Attributes
Table 87. Aurigene Pharmaceutical Services Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Aurigene Pharmaceutical Services Recent Developments
Table 89. Biocytogen Corporation Information
Table 90. Biocytogen Description and Major Businesses
Table 91. Biocytogen Product Features and Attributes
Table 92. Biocytogen Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Biocytogen Recent Developments
Table 94. Biomolecular Discovery Services Corporation Information
Table 95. Biomolecular Discovery Services Description and Major Businesses
Table 96. Biomolecular Discovery Services Product Features and Attributes
Table 97. Biomolecular Discovery Services Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Biomolecular Discovery Services Recent Developments
Table 99. Biotem Corporation Information
Table 100. Biotem Description and Major Businesses
Table 101. Biotem Product Features and Attributes
Table 102. Biotem Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Biotem Recent Developments
Table 104. Charles River Laboratories Corporation Information
Table 105. Charles River Laboratories Description and Major Businesses
Table 106. Charles River Laboratories Product Features and Attributes
Table 107. Charles River Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Charles River Laboratories Recent Developments
Table 109. ChemPartner Corporation Information
Table 110. ChemPartner Description and Major Businesses
Table 111. ChemPartner Product Features and Attributes
Table 112. ChemPartner Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. ChemPartner Recent Developments
Table 114. Creative Bioarray Corporation Information
Table 115. Creative Bioarray Description and Major Businesses
Table 116. Creative Bioarray Product Features and Attributes
Table 117. Creative Bioarray Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Creative Bioarray Recent Developments
Table 119. Creative Biolabs Corporation Information
Table 120. Creative Biolabs Description and Major Businesses
Table 121. Creative Biolabs Product Features and Attributes
Table 122. Creative Biolabs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. Creative Biolabs Recent Developments
Table 124. Curia Corporation Information
Table 125. Curia Description and Major Businesses
Table 126. Curia Product Features and Attributes
Table 127. Curia Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. Curia Recent Developments
Table 129. Eurofins Corporation Information
Table 130. Eurofins Description and Major Businesses
Table 131. Eurofins Product Features and Attributes
Table 132. Eurofins Revenue (US$ Million) and Gross Margin (2020-2025)
Table 133. Eurofins Recent Developments
Table 134. Evotec Corporation Information
Table 135. Evotec Description and Major Businesses
Table 136. Evotec Product Features and Attributes
Table 137. Evotec Revenue (US$ Million) and Gross Margin (2020-2025)
Table 138. Evotec Recent Developments
Table 139. GenScript Corporation Information
Table 140. GenScript Description and Major Businesses
Table 141. GenScript Product Features and Attributes
Table 142. GenScript Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. GenScript Recent Developments
Table 144. Integrated DNA Technologies Corporation Information
Table 145. Integrated DNA Technologies Description and Major Businesses
Table 146. Integrated DNA Technologies Product Features and Attributes
Table 147. Integrated DNA Technologies Revenue (US$ Million) and Gross Margin (2020-2025)
Table 148. Integrated DNA Technologies Recent Developments
Table 149. LakePharma Corporation Information
Table 150. LakePharma Description and Major Businesses
Table 151. LakePharma Product Features and Attributes
Table 152. LakePharma Revenue (US$ Million) and Gross Margin (2020-2025)
Table 153. LakePharma Recent Developments
Table 154. MorphoSys Corporation Information
Table 155. MorphoSys Description and Major Businesses
Table 156. MorphoSys Product Features and Attributes
Table 157. MorphoSys Revenue (US$ Million) and Gross Margin (2020-2025)
Table 158. MorphoSys Recent Developments
Table 159. NanoCellect Corporation Information
Table 160. NanoCellect Description and Major Businesses
Table 161. NanoCellect Product Features and Attributes
Table 162. NanoCellect Revenue (US$ Million) and Gross Margin (2020-2025)
Table 163. NanoCellect Recent Developments
Table 164. ProteoGenix Corporation Information
Table 165. ProteoGenix Description and Major Businesses
Table 166. ProteoGenix Product Features and Attributes
Table 167. ProteoGenix Revenue (US$ Million) and Gross Margin (2020-2025)
Table 168. ProteoGenix Recent Developments
Table 169. Rapid Novor Corporation Information
Table 170. Rapid Novor Description and Major Businesses
Table 171. Rapid Novor Product Features and Attributes
Table 172. Rapid Novor Revenue (US$ Million) and Gross Margin (2020-2025)
Table 173. Rapid Novor Recent Developments
Table 174. Sanofi Corporation Information
Table 175. Sanofi Description and Major Businesses
Table 176. Sanofi Product Features and Attributes
Table 177. Sanofi Revenue (US$ Million) and Gross Margin (2020-2025)
Table 178. Sanofi Recent Developments
Table 179. Syd Labs Corporation Information
Table 180. Syd Labs Description and Major Businesses
Table 181. Syd Labs Product Features and Attributes
Table 182. Syd Labs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 183. Syd Labs Recent Developments
Table 184. Twist Bioscience Corporation Information
Table 185. Twist Bioscience Description and Major Businesses
Table 186. Twist Bioscience Product Features and Attributes
Table 187. Twist Bioscience Revenue (US$ Million) and Gross Margin (2020-2025)
Table 188. Twist Bioscience Recent Developments
Table 189. Yumab Corporation Information
Table 190. Yumab Description and Major Businesses
Table 191. Yumab Product Features and Attributes
Table 192. Yumab Revenue (US$ Million) and Gross Margin (2020-2025)
Table 193. Yumab Recent Developments
Table 194. Viva Biotech Corporation Information
Table 195. Viva Biotech Description and Major Businesses
Table 196. Viva Biotech Product Features and Attributes
Table 197. Viva Biotech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 198. Viva Biotech Recent Developments
Table 199. WuXi Biologics Corporation Information
Table 200. WuXi Biologics Description and Major Businesses
Table 201. WuXi Biologics Product Features and Attributes
Table 202. WuXi Biologics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 203. WuXi Biologics Recent Developments
Table 204. Raw Materials Key Suppliers
Table 205. Distributors List
Table 206. Market Trends and Market Evolution
Table 207. Market Drivers and Opportunities
Table 208. Market Challenges, Risks, and Restraints
Table 209. Research Programs/Design for This Report
Table 210. Key Data Information from Secondary Sources
Table 211. Key Data Information from Primary Sources


List of Figures
Figure 1. Antibody Discovery and Development Services Product Picture
Figure 2. Global Antibody Discovery and Development Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Antibody Discovery Services Product Picture
Figure 4. Antibody Production Services Product Picture
Figure 5. Global Antibody Discovery and Development Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Pharmaceutical
Figure 7. Research
Figure 8. Others
Figure 9. Antibody Discovery and Development Services Report Years Considered
Figure 10. Global Antibody Discovery and Development Services Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Antibody Discovery and Development Services Revenue (2020-2031) & (US$ Million)
Figure 12. Global Antibody Discovery and Development Services Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Antibody Discovery and Development Services Revenue Market Share by Region (2020-2031)
Figure 14. Global Antibody Discovery and Development Services Revenue Market Share Ranking (2024)
Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 16. Antibody Discovery Services Revenue Market Share by Player in 2024
Figure 17. Antibody Production Services Revenue Market Share by Player in 2024
Figure 18. Global Antibody Discovery and Development Services Revenue Market Share by Type (2020-2031)
Figure 19. Global Antibody Discovery and Development Services Revenue Market Share by Application (2020-2031)
Figure 20. North America Antibody Discovery and Development Services Revenue YoY (2020-2031) & (US$ Million)
Figure 21. North America Top 5 Players Antibody Discovery and Development Services Revenue (US$ Million) in 2024
Figure 22. North America Antibody Discovery and Development Services Revenue (US$ Million) by Type (2020 - 2031)
Figure 23. North America Antibody Discovery and Development Services Revenue (US$ Million) by Application (2020-2031)
Figure 24. US Antibody Discovery and Development Services Revenue (2020-2031) & (US$ Million)
Figure 25. Canada Antibody Discovery and Development Services Revenue (2020-2031) & (US$ Million)
Figure 26. Mexico Antibody Discovery and Development Services Revenue (2020-2031) & (US$ Million)
Figure 27. Europe Antibody Discovery and Development Services Revenue YoY (2020-2031) & (US$ Million)
Figure 28. Europe Top 5 Players Antibody Discovery and Development Services Revenue (US$ Million) in 2024
Figure 29. Europe Antibody Discovery and Development Services Revenue (US$ Million) by Type (2020-2031)
Figure 30. Europe Antibody Discovery and Development Services Revenue (US$ Million) by Application (2020-2031)
Figure 31. Germany Antibody Discovery and Development Services Revenue (2020-2031) & (US$ Million)
Figure 32. France Antibody Discovery and Development Services Revenue (2020-2031) & (US$ Million)
Figure 33. U.K. Antibody Discovery and Development Services Revenue (2020-2031) & (US$ Million)
Figure 34. Italy Antibody Discovery and Development Services Revenue (2020-2031) & (US$ Million)
Figure 35. Russia Antibody Discovery and Development Services Revenue (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Antibody Discovery and Development Services Revenue YoY (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Top 8 Players Antibody Discovery and Development Services Revenue (US$ Million) in 2024
Figure 38. Asia-Pacific Antibody Discovery and Development Services Revenue (US$ Million) by Type (2020-2031)
Figure 39. Asia-Pacific Antibody Discovery and Development Services Revenue (US$ Million) by Application (2020-2031)
Figure 40. Indonesia Antibody Discovery and Development Services Revenue (2020-2031) & (US$ Million)
Figure 41. Japan Antibody Discovery and Development Services Revenue (2020-2031) & (US$ Million)
Figure 42. South Korea Antibody Discovery and Development Services Revenue (2020-2031) & (US$ Million)
Figure 43. Australia Antibody Discovery and Development Services Revenue (2020-2031) & (US$ Million)
Figure 44. India Antibody Discovery and Development Services Revenue (2020-2031) & (US$ Million)
Figure 45. Indonesia Antibody Discovery and Development Services Revenue (2020-2031) & (US$ Million)
Figure 46. Vietnam Antibody Discovery and Development Services Revenue (2020-2031) & (US$ Million)
Figure 47. Malaysia Antibody Discovery and Development Services Revenue (2020-2031) & (US$ Million)
Figure 48. Philippines Antibody Discovery and Development Services Revenue (2020-2031) & (US$ Million)
Figure 49. Singapore Antibody Discovery and Development Services Revenue (2020-2031) & (US$ Million)
Figure 50. Central and South America Antibody Discovery and Development Services Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Central and South America Top 5 Players Antibody Discovery and Development Services Revenue (US$ Million) in 2024
Figure 52. Central and South America Antibody Discovery and Development Services Revenue (US$ Million) by Type (2020-2031)
Figure 53. Central and South America Antibody Discovery and Development Services Revenue (US$ Million) by Application (2020-2031)
Figure 54. Brazil Antibody Discovery and Development Services Revenue (2020-2025) & (US$ Million)
Figure 55. Argentina Antibody Discovery and Development Services Revenue (2020-2025) & (US$ Million)
Figure 56. Middle East and Africa Antibody Discovery and Development Services Revenue YoY (2020-2031) & (US$ Million)
Figure 57. Middle East and Africa Top 5 Players Antibody Discovery and Development Services Revenue (US$ Million) in 2024
Figure 58. South America Antibody Discovery and Development Services Revenue (US$ Million) by Type (2020-2031)
Figure 59. Middle East and Africa Antibody Discovery and Development Services Revenue (US$ Million) by Application (2020-2031)
Figure 60. GCC Countries Antibody Discovery and Development Services Revenue (2020-2025) & (US$ Million)
Figure 61. Israel Antibody Discovery and Development Services Revenue (2020-2025) & (US$ Million)
Figure 62. Egypt Antibody Discovery and Development Services Revenue (2020-2025) & (US$ Million)
Figure 63. South Africa Antibody Discovery and Development Services Revenue (2020-2025) & (US$ Million)
Figure 64. Antibody Discovery and Development Services Industry Chain Mapping
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit